About Invicro

Headquartered in the US, Invicro is a next-generation quantitative imaging biomarker company focused on accelerating the discovery and development of life-changing medicines. With laboratories in the US, UK, India, Japan and China, Invicro is a global research partner to numerous pharmaceutical, biotech and contract research organizations, leveraging its platform to combine best-in-class expertise, imaging biomarkers, core lab services, analytics, and software. Its medical imaging capabilities are helping to achieve better patient outcomes in key therapeutic areas including oncology, central nervous system and respiratory, as well as meet the growing demand for enhanced imaging and new therapies in fast-growing specialties such as radiotherapy, gastroenterology, inflammation, fibrosis and mitochondrial imaging.

Click below to tour our global sites…



Transform healthcare via innovative imaging applications and informatics


Visualize and quantify biological and pathological processes to better diagnose, treat, and cure disease through advanced imaging applications, informatics, and operations supporting drug research and development

The Invicro Platform

Invicro solves drug development problems using a platform that harnesses the unique depth and breadth of our expertise in science, medicine, imaging, operations, analytics, and software. The Invicro platform provides high-quality Design, Capture, Analysis and Management of data—across the drug development pipeline.


Our experts and agnostic technology give us the ability to better design customized studies. With the largest team of PhD’s and MD’s in the industry. Invicro’s scientists utilize the most powerful open-architected technology to better customize studies based on your specific questions.


Our broad range of available modalities are managed by expert scientists to ensure delivery of high-quality, consistent, quantifiable data from both imaging and non-imaging sources to meet the needs of the study design.


Invicro’s world-class analytics team, aided by state-of-the-art software including VivoQuant®, MIAKAT and IQ analytics, delivers advanced domain knowledge and machine learning for deeper understanding and insight.


The integration of our VivoQuant® and iPACS® management software provides an unsurpassed collaborative experience in end-to-end data management, from discovery to Phase IV clinical trials.